We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

48 hedge funds and large institutions have $43.7M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

45% more capital invested

Capital invested by funds: $30.1M → $43.7M (+$13.6M)

30% more funds holding

Funds holding: 37 → 48 (+11)

1.52% less ownership

Funds ownership: 21.14% → 19.62% (-1.5%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
48
Holders Change
+11
Holders Change %
+29.73%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
12
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$3.36M
2
SWM
Strategic Wealth Management
Washington
+$1.75M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.04M
4
WAP
Wealthcare Advisory Partners
Pennsylvania
+$948K
5
LPL Financial
LPL Financial
California
+$907K

Top Sellers

Rank Fund Capital Flow
1
RCS
Retirement Capital Strategies
California
-$5.99M
2
Jane Street
Jane Street
New York
-$1.17M
3
SFS
Sowell Financial Services
Arkansas
-$616K
4
PAG
Private Advisor Group
New Jersey
-$314K
5
TA
TCG Advisors
Texas
-$280K
Name Holding Trade Value Shares
Change 		Change in
Stake
JIR
26
James Investment Research
Ohio
$219K – – –
SPC
27
Sigma Planning Corp
Michigan
$217K +$215K +5,580 New
TWM
28
Tolleson Wealth Management
Texas
$208K +$205K +5,334 New
ASN
29
Advisory Services Network
Georgia
$201K +$198K +5,160 New
Osaic Holdings
30
Osaic Holdings
Arizona
$127K +$50.9K +1,325 +69%
IA
31
IFP Advisors
Florida
$101K +$53.7K +1,398 +121%
HWA
32
HHM Wealth Advisors
Tennessee
$34K – – –
PA
33
Parallel Advisors
California
$33K +$3.58K +93 +12%
CAPTRUST Financial Advisors
34
CAPTRUST Financial Advisors
North Carolina
$21K +$20.2K +525 New
NFG
35
Next Financial Group
Texas
$18K +$17.3K +450 New
SWM
36
Sugarloaf Wealth Management
Georgia
$15K – – –
CFGS
37
Concourse Financial Group Securities
Alabama
$11K +$10.6K +275 New
APA
38
American Portfolios Advisors
New York
$10.7K -$151K -3,928 -93%
PFGIA
39
Patriot Financial Group Insurance Agency
Massachusetts
$8K -$8.19K -213 -51%
GEA
40
Glen Eagle Advisors
New Jersey
$7.79K – – –
PFS
41
Prospera Financial Services
Texas
$5K +$4.81K +125 New
TF
42
TimeScale Financial
Massachusetts
$5K +$4.84K +126 New
EIP
43
Ellis Investment Partners
Pennsylvania
$5K +$5K +130 New
NSIM
44
North Star Investment Management
Illinois
$4K +$3.85K +100 New
WIM
45
Westside Investment Management
California
$3.9K – – –
TCOV
46
Trust Company of Vermont
Vermont
$2K – – –
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$2K +$2.31K +60 New
RWG
48
Regal Wealth Group
California
$1K -$231 -6 -15%
CYG
49
Clean Yield Group
Vermont
$1K +$1.31K +34 New
Jane Street
50
Jane Street
New York
– -$1.17M -30,721 Closed
1
2
3

IDNA Hedge Fund Activity: Q3 2020 in Review

48 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2020, worth a combined $43.7M — up 45% from $30.1M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IDNA positions and 9 closed out — a net gain of 11 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was UBS Group, adding an estimated $3.36M. The largest seller was Retirement Capital Strategies, cutting an estimated $5.99M.

  • 48 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2020, up from 37 in Q2 2020.
  • Funds reported $43.7M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2020, up 45% quarter-over-quarter.
  • 20 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2020 and 9 closed out, a net change of +11 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2020 was UBS Group, an estimated $3.36M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2020 was Retirement Capital Strategies, an estimated $5.99M sold.

Based on aggregated 13F filings for Q3 2020.